Latest Articles
Latest
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
IWMF Welcomes Two New Staff Members
Two new team members join IWMF IWMF is pleased to welcome two new staff members whose leadership, experience, and commitment to mission-driven work will help strengthen the organization’s donor engagement, volunteer leadership, executive operations, and governance...
For the First Time: Patients Invited to IWWM-13 Highlights Recap Session
For the first time ever, WM patients and caregivers are invited to this global gathering. Free October 17 session in Palm Springs will recap key scientific updates from the 13th International Workshop on Waldenstrom’s Macroglobulinemia into practical takeaways for the...
Patient Voices at EHA 2026 Congress
Patient Voices at the EHA 2026 Congress by Hannah Mobarak, IWMF Global Partner Manager (pictured on far right with Dina Steagall and Prof. Shirley D'Sa)Stockholm, Sweden This year, the European Hematology Association brought the global hematology community...
IWMF Welcomes New Grants and Contracts Administrator
A new team member joins IWMF The International Waldenstrom Macroglobulinemia Foundation (IWMF) is pleased to announce the addition of Kim Schwartz as its new Grants and Contracts Administrator. Kim's Background Kim has over 6 years of experience in nonprofit grants...
4th Annual European Educational Forum
European Educational Forum - Athens, Greeceby Hannah Mobarak, IWMF Global Partner ManagerOn Friday 24 April, we hosted our 4th Annual European Educational Forum in Athens, Greece, bringing together the international WM community in one place to learn from...
IWMF Welcomes New Chief Development Officer
A new team member joins IWMF We are delighted to welcome Katie Warrensford as the new Chief Development Officer of the International Waldenstrom Macroglobulinemia Foundation. Katie's Background Katie is a dynamic nonprofit executive with more than 20 years of...
Subscribe Today!
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean scelerisque suscipit condimentum. Vestibulum in scelerisque eros. Fusce sed massa vel sem commodo.
Featured Story
Lorem ipsum dolor sit consectetur adipiscing elit.
Proin eget tortor risus. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Curabitur aliquet quam id dui posuere blandit. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Sed porttitor lectus nibh. Cras ultricies ligula sed magna dictum porta. Proin eget tortor risus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Nulla quis lorem ut libero malesuada feugiat.
Pellentesque in ipsum id orci porta dapibus. Nulla porttitor accumsan tincidunt. Nulla quis lorem ut libero malesuada feugiat. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Donec velit neque, auctor sit amet aliquam vel, ullamcorper sit amet ligula. Vivamus suscipit tortor eget felis porttitor volutpat. Proin eget tortor risus. Cras ultricies ligula sed magna dictum porta. Proin eget tortor risus. Vivamus suscipit tortor eget felis porttitor volutpat.
Featured Author
Vestibulum Malesuada Non Magna Lacinia
Proin eget tortor risus. Praesent sapien massa, convallis a pellentesque nec, egestas no
Staff Picks
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
IWMF Welcomes Two New Staff Members
Two new team members join IWMF IWMF is pleased to welcome two new staff members whose leadership, experience, and commitment to mission-driven work will help strengthen the organization’s donor engagement, volunteer leadership, executive operations, and governance...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
IWMF Welcomes Two New Staff Members
Two new team members join IWMF IWMF is pleased to welcome two new staff members whose leadership, experience, and commitment to mission-driven work will help strengthen the organization’s donor engagement, volunteer leadership, executive operations, and governance...
For the First Time: Patients Invited to IWWM-13 Highlights Recap Session
For the first time ever, WM patients and caregivers are invited to this global gathering. Free October 17 session in Palm Springs will recap key scientific updates from the 13th International Workshop on Waldenstrom’s Macroglobulinemia into practical takeaways for the...
Patient Voices at EHA 2026 Congress
Patient Voices at the EHA 2026 Congress by Hannah Mobarak, IWMF Global Partner Manager (pictured on far right with Dina Steagall and Prof. Shirley D'Sa)Stockholm, Sweden This year, the European Hematology Association brought the global hematology community...
IWMF Welcomes New Grants and Contracts Administrator
A new team member joins IWMF The International Waldenstrom Macroglobulinemia Foundation (IWMF) is pleased to announce the addition of Kim Schwartz as its new Grants and Contracts Administrator. Kim's Background Kim has over 6 years of experience in nonprofit grants...
Popular Categories
Categories
Gadgets & Devices
Fashion
Travel
Trending Now
Hot
Latest Trending
Featured Trending
Staff Picks
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
IWMF Welcomes Two New Staff Members
Two new team members join IWMF IWMF is pleased to welcome two new staff members whose leadership, experience, and commitment to mission-driven work will help strengthen the organization’s donor engagement, volunteer leadership, executive operations, and governance...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
IWMF Welcomes Two New Staff Members
Two new team members join IWMF IWMF is pleased to welcome two new staff members whose leadership, experience, and commitment to mission-driven work will help strengthen the organization’s donor engagement, volunteer leadership, executive operations, and governance...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
IWMF Welcomes Two New Staff Members
Two new team members join IWMF IWMF is pleased to welcome two new staff members whose leadership, experience, and commitment to mission-driven work will help strengthen the organization’s donor engagement, volunteer leadership, executive operations, and governance...
Vestibulum Malesuada Non Magna Lacinia
Home Office
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
IWMF Welcomes Two New Staff Members
Two new team members join IWMF IWMF is pleased to welcome two new staff members whose leadership, experience, and commitment to mission-driven work will help strengthen the organization’s donor engagement, volunteer leadership, executive operations, and governance...
For the First Time: Patients Invited to IWWM-13 Highlights Recap Session
For the first time ever, WM patients and caregivers are invited to this global gathering. Free October 17 session in Palm Springs will recap key scientific updates from the 13th International Workshop on Waldenstrom’s Macroglobulinemia into practical takeaways for the...
Patient Voices at EHA 2026 Congress
Patient Voices at the EHA 2026 Congress by Hannah Mobarak, IWMF Global Partner Manager (pictured on far right with Dina Steagall and Prof. Shirley D'Sa)Stockholm, Sweden This year, the European Hematology Association brought the global hematology community...
IWMF Welcomes New Grants and Contracts Administrator
A new team member joins IWMF The International Waldenstrom Macroglobulinemia Foundation (IWMF) is pleased to announce the addition of Kim Schwartz as its new Grants and Contracts Administrator. Kim's Background Kim has over 6 years of experience in nonprofit grants...
Our Recommended Products
Shop
